Cargando…

Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis

BACKGROUND: In clinical trials, pregnant women are potentially vulnerable, and the fetus is exposed to the intervention. This study aimed to identify the reasons that led pregnant women at a high risk of premature delivery to participate in a randomized clinical trial. METHODS: The women participati...

Descripción completa

Detalles Bibliográficos
Autores principales: Monteiro, Thaís M., Katz, Leila, Bento, Silvana F., Amorim, Melania M., Moriel, Patrícia C., Pacagnella, Rodolfo C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425624/
https://www.ncbi.nlm.nih.gov/pubmed/30894167
http://dx.doi.org/10.1186/s12884-019-2240-8
_version_ 1783404874411540480
author Monteiro, Thaís M.
Katz, Leila
Bento, Silvana F.
Amorim, Melania M.
Moriel, Patrícia C.
Pacagnella, Rodolfo C.
author_facet Monteiro, Thaís M.
Katz, Leila
Bento, Silvana F.
Amorim, Melania M.
Moriel, Patrícia C.
Pacagnella, Rodolfo C.
author_sort Monteiro, Thaís M.
collection PubMed
description BACKGROUND: In clinical trials, pregnant women are potentially vulnerable, and the fetus is exposed to the intervention. This study aimed to identify the reasons that led pregnant women at a high risk of premature delivery to participate in a randomized clinical trial. METHODS: The women participating in the main trial were contacted by telephone postpartum and invited to answer an open questionnaire in a cross-sectional study. Data were collected by telephone and analyzed using thematic analysis. After the analysis categories were defined, all the answers were reviewed, categorized and grouped. A descriptive summary of the content of each category was then made. RESULTS: Overall, 208 women from different geographical regions of the country agreed to participate. Four categories were identified: 1) The risk of losing the baby; 2) A previous experience of premature delivery; 3) The role of the doctor and other health professionals, and 4) The availability of quality medical care and free medication. The main reason given for agreeing to participate was to reduce the risks associated with the baby being born prematurely, particularly when the woman herself or someone close to her had already experienced premature delivery. Other reasons were having received clear guidance and explanations from the doctor regarding prematurity and about the study and being given the opportunity to receive free treatment with greater access to the public healthcare system. CONCLUSIONS: The decision to participate in a clinical trial is not easy, particularly when the individual is vulnerable and in a critical situation as in the case of a pregnant woman at a high risk of delivering prematurely. Fears and uncertainties regarding the pregnancy outcome, as well as the woman’s previous experiences and her awareness of the actual risks she faces will affect her decision regarding whether or not to participate. Recruitment challenges could be overcome by ensuring that the research team provides adequate information and support, thus creating a bond with participants that would foster a sense of safety and trust in the study proposals. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12884-019-2240-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6425624
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64256242019-03-29 Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis Monteiro, Thaís M. Katz, Leila Bento, Silvana F. Amorim, Melania M. Moriel, Patrícia C. Pacagnella, Rodolfo C. BMC Pregnancy Childbirth Research Article BACKGROUND: In clinical trials, pregnant women are potentially vulnerable, and the fetus is exposed to the intervention. This study aimed to identify the reasons that led pregnant women at a high risk of premature delivery to participate in a randomized clinical trial. METHODS: The women participating in the main trial were contacted by telephone postpartum and invited to answer an open questionnaire in a cross-sectional study. Data were collected by telephone and analyzed using thematic analysis. After the analysis categories were defined, all the answers were reviewed, categorized and grouped. A descriptive summary of the content of each category was then made. RESULTS: Overall, 208 women from different geographical regions of the country agreed to participate. Four categories were identified: 1) The risk of losing the baby; 2) A previous experience of premature delivery; 3) The role of the doctor and other health professionals, and 4) The availability of quality medical care and free medication. The main reason given for agreeing to participate was to reduce the risks associated with the baby being born prematurely, particularly when the woman herself or someone close to her had already experienced premature delivery. Other reasons were having received clear guidance and explanations from the doctor regarding prematurity and about the study and being given the opportunity to receive free treatment with greater access to the public healthcare system. CONCLUSIONS: The decision to participate in a clinical trial is not easy, particularly when the individual is vulnerable and in a critical situation as in the case of a pregnant woman at a high risk of delivering prematurely. Fears and uncertainties regarding the pregnancy outcome, as well as the woman’s previous experiences and her awareness of the actual risks she faces will affect her decision regarding whether or not to participate. Recruitment challenges could be overcome by ensuring that the research team provides adequate information and support, thus creating a bond with participants that would foster a sense of safety and trust in the study proposals. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12884-019-2240-8) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-20 /pmc/articles/PMC6425624/ /pubmed/30894167 http://dx.doi.org/10.1186/s12884-019-2240-8 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Monteiro, Thaís M.
Katz, Leila
Bento, Silvana F.
Amorim, Melania M.
Moriel, Patrícia C.
Pacagnella, Rodolfo C.
Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis
title Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis
title_full Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis
title_fullStr Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis
title_full_unstemmed Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis
title_short Reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis
title_sort reasons given by pregnant women for participating in a clinical trial aimed at preventing premature delivery: a qualitative analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425624/
https://www.ncbi.nlm.nih.gov/pubmed/30894167
http://dx.doi.org/10.1186/s12884-019-2240-8
work_keys_str_mv AT monteirothaism reasonsgivenbypregnantwomenforparticipatinginaclinicaltrialaimedatpreventingprematuredeliveryaqualitativeanalysis
AT katzleila reasonsgivenbypregnantwomenforparticipatinginaclinicaltrialaimedatpreventingprematuredeliveryaqualitativeanalysis
AT bentosilvanaf reasonsgivenbypregnantwomenforparticipatinginaclinicaltrialaimedatpreventingprematuredeliveryaqualitativeanalysis
AT amorimmelaniam reasonsgivenbypregnantwomenforparticipatinginaclinicaltrialaimedatpreventingprematuredeliveryaqualitativeanalysis
AT morielpatriciac reasonsgivenbypregnantwomenforparticipatinginaclinicaltrialaimedatpreventingprematuredeliveryaqualitativeanalysis
AT pacagnellarodolfoc reasonsgivenbypregnantwomenforparticipatinginaclinicaltrialaimedatpreventingprematuredeliveryaqualitativeanalysis